CCNB1 and non-small cell lung carcinoma: In addition, the overexpression of Cyclin B1 has been identified as a promising poor prognostic marker in patients with hepatocellular cancer, non-small cell lung cancer, and head-neck squamous cell carcinoma [32, 34, 43].